These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2184654)

  • 61. Indapamide versus beta-blocker therapy: a double-blind, crossover study in essential hypertension.
    Rumboldt Z; Rumboldt M; Jurisic M
    Curr Med Res Opin; 1984; 9(1):10-20. PubMed ID: 6373155
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Antihypertensive treatment: a combination of delapril, a new ACE-inhibitor, and indapamide].
    Coruzzi P; Ravanetti C; Alberici M; Novarini A
    Clin Ter; 1990 Jan; 132(1):45-9. PubMed ID: 2139371
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A comparative study of the activity of a new agent, indapamide, in essential arterial hypertension.
    Hatt PY; Leblond JB
    Curr Med Res Opin; 1975; 3(3):138-44. PubMed ID: 1097194
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008117. PubMed ID: 24488616
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Combined antihypertensive therapy in patients with arterial hypertension and type 2 diabetes].
    Nesterov IuI; Poltavtseva OV; Bondareva IN; Tepliakov AT
    Klin Med (Mosk); 2009; 87(8):29-32. PubMed ID: 19827527
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Multicenter dose-response study of the effect of indapamide in the treatment of patients with mild to moderate hypertension.
    Capone P; Vukovich RA; Neiss ES; Bolton S; Reeves RL
    Clin Ther; 1983; 5(3):305-16. PubMed ID: 6342786
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of blood pressure control with perindopril/indapamide on the microcirculation in hypertensive patients.
    Debbabi H; Bonnin P; Levy BI
    Am J Hypertens; 2010 Oct; 23(10):1136-43. PubMed ID: 20508624
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical positioning of indapamide sustained release 1.5mg in management protocols for hypertension.
    Leonetti G
    Drugs; 2000; 59 Suppl 2():27-38; discussion 39-40. PubMed ID: 10678595
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study.
    London G; Schmieder R; Calvo C; Asmar R
    Am J Hypertens; 2006 Jan; 19(1):113-21. PubMed ID: 16461202
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effects of antihypertensive therapy on the quality of life.
    Croog SH; Levine S; Testa MA; Brown B; Bulpitt CJ; Jenkins CD; Klerman GL; Williams GH
    N Engl J Med; 1986 Jun; 314(26):1657-64. PubMed ID: 3520318
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The effect of treatment with low dose ACE inhibitor and/or diuretic on coronary microvasculature in stroke-prone spontaneously hypertensive rats.
    Rakusan K; Cicutti N; Maurin A; Guez D; Schiavi P
    Microvasc Res; 2000 Mar; 59(2):243-54. PubMed ID: 10684730
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hypertension and micro-albuminuria in diabetic patients taking indapamide.
    Janka HU; Weitz T; Blümner E; van Michel A; Mehnert H
    J Hypertens Suppl; 1989 Dec; 7(6):S316-7. PubMed ID: 2632730
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Multi-centre clinical investigation of indapamide in the United States: a review.
    Vukovich RA; Zisblatt M; Caruso F; Losi M; Barton J; Schotz WE; Webb E; Eff J; Bronstein R; Neiss ES
    Curr Med Res Opin; 1983; 8 Suppl 3():109-22. PubMed ID: 6352183
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A preliminary controlled evaluation of the antihypertensive effect of indapamide.
    Turner P; Volans GN; Rogers HJ
    Curr Med Res Opin; 1977; 4(8):596-601. PubMed ID: 326495
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Twenty-four hour antihypertensive efficacy of indapamide, 1.5-mg sustained release: results of two randomized double-blind controlled studies.
    Mallion JM; Asmar R; Boutelant S; Guez D
    J Cardiovasc Pharmacol; 1998 Oct; 32(4):673-8. PubMed ID: 9781939
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of once daily indapamide and pindolol on blood pressure, plasma aldosterone concentration and plasma renin activity in a general practice setting.
    Chalmers JP; Wing LM; Grygiel JJ; West MJ; Graham JR; Bune AJ
    Eur J Clin Pharmacol; 1982; 22(3):191-6. PubMed ID: 7049706
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A fresh approach to the evaluation of antihypertensive agents.
    Campbell DB; Lowe S; Taylor D; Turner P; Walsh N
    Hypertension; 1985; 7(6 Pt 2):II143-51. PubMed ID: 2867039
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Twenty-four-hour blood pressure monitoring and effects of indapamide.
    Ocon J; Mora J
    Am J Cardiol; 1990 May; 65(17):58H-61H. PubMed ID: 2330908
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Once daily indapamide in the treatment of the elderly and young hypertensive.
    Rowlands DB; Glover DR; Young MA; Stallard TJ; Littler WA
    Eur J Clin Pharmacol; 1984; 27(4):397-405. PubMed ID: 6394348
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antihypertensive activity of a new agent, indapamide: a double-blind study.
    Milliez P; Tcherdakoff P
    Curr Med Res Opin; 1975; 3(1):9-15. PubMed ID: 1090418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.